Results 31 to 40 of about 53,065 (244)

Ectopic corticotroph syndrome [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2004
INTRODUCTION Endogenous Cushing's syndrome is a clinical state resulting from prolonged, inappropriate exposure to excessive endogenous secretion of Cortisol and hence excess circulating free cortisol, characterized by loss of the normal feedback ...
Penezić Zorana   +5 more
doaj   +1 more source

Hedinger Syndrome—Lessons Learnt: A Single-Center Experience

open access: yesJournal of Cardiovascular Development and Disease, 2023
Background: Hedinger syndrome (HS) or carcinoid heart disease (CD) is a rare and challenging manifestation of malignant neuroendocrine tumours (NETs) involving the heart.
Mohamed El Gabry   +6 more
doaj   +1 more source

Somatostatin Analogues in the Treatment of Neuroendocrine Tumors: Past, Present and Future [PDF]

open access: yes, 2019
In recent decades, the incidence of neuroendocrine tumors (NETs) has steadily increased. Due to the slow-growing nature of these tumors and the lack of early symptoms, most cases are diagnosed at advanced stages, when curative treatment options are no ...
Amthauer, Holger   +8 more
core   +1 more source

A novel mutation of the MEN1 gene in a patient with multiple endocrine neoplasia type 1 and recurrent fibromyxoid sarcoma – a case report

open access: yesBMC Medical Genetics, 2020
Background Multiple endocrine neoplasia type 1 (MEN1) syndrome is usually accompanied by endocrine tumors, but non-endocrine tumors can occur as well. However, the coexistence of MEN1 syndrome and malignant tumor such as low-grade fibromyxoid sarcoma has
Maja Radman, Tanja Milicevic
doaj   +1 more source

Carcinoid syndrome caused by a pulmonary carcinoid mimics intestinal manifestations of ulcerative colitis: A case report

open access: yesWorld Journal of Gastroenterology, 2023
BACKGROUND Pulmonary carcinoids are rare, low-grade malignant tumors characterized by neuroendocrine differentiation and relatively indolent clinical behavior.
Carmen Mota Reyes   +7 more
semanticscholar   +1 more source

Primary carcinoid tumors at atypical sites: surgery is mandatory and size determines survival—an Egyptian study

open access: yesBulletin of the National Research Centre, 2019
Background Carcinoids at atypical sites are rare and mostly asymptomatic. In the majority, they show normal levels of serotonin and its metabolites in plasma and urine, resulting in a relatively late diagnosis and hence guarded prognosis.
Karim G. Moustafa, Gamal M. Saied
doaj   +1 more source

Targeted treatment with somatostatin analogues: widening horizons of clinical practice

open access: yesAlʹmanah Kliničeskoj Mediciny, 2022
Targeted treatment with somatostatin analogues (SA) in acromegaly and neuroendocrine neoplasms may have some benefits compared to curative treatments, because these agents decrease excessive hormone secretion and exert a tumor-suppressive effect ...
Vyacheslav S. Pronin   +3 more
doaj   +1 more source

High-Dose Lanreotide in the Treatment of Poorly Differentiated Pancreatic Neuroendocrine Carcinoma: A Case Report

open access: yesCase Reports in Oncology, 2014
Pancreatic neuroendocrine tumors (NETs), including poorly differentiated carcinomas (NECs), are rarely encountered. The majority of these tumors do not secrete excess hormones, but functioning NETs produce large amounts of vasoactive peptides and may ...
Frank Van Fraeyenhove   +7 more
doaj   +1 more source

Expressions of Cushing’s syndrome in multiple endocrine neoplasia type 1

open access: yesFrontiers in Endocrinology, 2023
Cushing’s syndrome (CS) resulting from endogenous hypercortisolism can be sporadic or can occur in the context of familial disease because of pituitary or extra-pituitary neuroendocrine tumors.
William F. Simonds
doaj   +1 more source

Phase 3 Trial of 177Lu-Dotatate for Midgut Neuroendocrine Tumors [PDF]

open access: yes, 2017
Background Patients with advanced midgut neuroendocrine tumors who have had disease progression during first-line somatostatin analogue therapy have limited therapeutic options.
Al‐nahhas, A   +82 more
core   +1 more source

Home - About - Disclaimer - Privacy